Iconic Brands Inc (ICNB)

[Drugdoctor]

LOL LOL - You need to read the NEWS!! And the FINANCIALS!!


On November 12, 2015, Bellissima Spirits LLC (“Bellissima”) entered into a License
Agreement with Christie Brinkley, Inc. (the “Bellissima Licensor”), an entity owned by
Christie Brinkley (“Brinkley”), to use Brinkley’s endorsement, signature, and other
intellectual property owned by the Bellissima Licensor. Iconic has agreed to guarantee and act
as surety for Bellissima’s obligations under certain sections of the License Agreement and to
indemnify the Bellissima Licensor and Brinkley against third party claims. Also, Brinkley was
granted a 24 month option to purchase 1% of the outstanding shares of Iconic common stock
on a fully diluted basis (as of the date of Brinkley’s exercise of the option) at an exercise price
of $0.001 per share.
c. Royalty Obligations of BiVi and Bellissima
Pursuant to the License Agreement with the Bivi Licensor (see note 9b. above), BiVi is
obligated to pay the BiVi Licensor a Royalty Fee equal to 5% of monthly gross sales of BiVi
Brand products payable monthly subject to an annual Minimum Royalty Fee of $100,000 in
year 1, $150,000 in year 2, $165,000 in year 3, $181,500 in year 4, $199,650 in year 5, and
$219,615 in year 6 and each subsequent year.
Pursuant to the License Agreement with the Bellissima Licensor (see note 9b. above),
Bellissima is obligated to pay the Bellissima Licensor a Royalty Fee equal to 10% of monthly
gross sales of Bellissima Brand products payable monthly. The Bellissima Licensor has the
right to terminate the endorsement if Bellissima fails to sell 10,000 cases of Bellissima Brand
products in year 1, 15,000 cases in year 2, or 20,000 cases in year 3 and each subsequent year.

https://www.otcmarkets.com/financialReportViewer?symbol=ICNB&id=164765